Category: Research

Elderly diabetic patients who received structured care after bypass surgery showed significantly better heart function and blood sugar control than those receiving routine care alone The 6-month program included cardiac rehabilitation, Mediterranean diet guidance, psychological support, and intensive follow-up Patients also walked farther, had better cholesterol levels, and reported higher quality of life

Inhaled GM-CSF improved oxygen transfer in the lungs and reduced breathing difficulty in patients with autoimmune pulmonary alveolar proteinosis Analysis included 402 patients across four clinical trials with at least 25 weeks of follow-up Treatment showed a favorable safety profile with no major differences between continuous and intermittent dosing schedules

People with allergic rhinitis face nearly 3 times the risk of migraine Analysis included over 4.8 million participants across 10 studies Results suggest 23-82 additional migraine cases per 1,000 people with allergic rhinitis

Type 2 diabetes patients show significantly elevated levels of both oxidative stress markers (F2-isoprostanes and 8-OHdG) Parkinson\’s disease patients show only moderately elevated 8-OHdG levels, with no significant F2-isoprostanes elevation The distinct profiles suggest 8-OHdG may be particularly useful for monitoring patients with both conditions

Pemphigus vulgaris during pregnancy should be considered high-risk, requiring close monitoring Disease control and remission before pregnancy significantly improves outcomes for mother and baby Neonatal pemphigus occurred in 38% of cases, fetal mortality was 9.8%, and post-partum flares in 37%

Noninvasive vagal nerve stimulation (nVNS) reduced migraine pain and frequency in chronic migraine patients Quality of life scores improved significantly in the treatment group Effects were measured over 4 weeks of active stimulation

FPGS rs1544105 T allele linked to 66% higher odds of better methotrexate response but also increased toxicity risk FPGS rs10106 G allele associated with 22% improved efficacy and consistently higher toxicity across all genetic models Effects observed mainly in Asian and European populations, not in US/Other groups

Among 13,000 patients in 56 secukinumab trials, zero cases of new-onset lupus were reported Only seven case reports exist of lupus developing after starting IL-17 inhibitors across all available drugs Four patients with active lupus treated with secukinumab showed variable responses, but data quality was limited

Nearly 1 in 4 youth with type 2 diabetes experience depression Depression rates were higher in those with better blood sugar control (HbA1c < 7%) Self-report screening tools detected more cases than clinical diagnostic interviews